128 related articles for article (PubMed ID: 8324446)
1. Screening for ovarian cancer. Other malignancies cloud the issue.
Clements D
BMJ; 1993 Jun; 306(6893):1685. PubMed ID: 8324446
[No Abstract] [Full Text] [Related]
2. Screening in ovarian cancer.
Creasman WT; DiSaia PJ
Am J Obstet Gynecol; 1991 Jul; 165(1):7-10. PubMed ID: 1853918
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer screening.
van Nagell JR
Cancer; 1991 Aug; 68(4):679-80. PubMed ID: 1855166
[No Abstract] [Full Text] [Related]
4. Screening for ovarian cancer.
Powell MA
J Am Acad Nurse Pract; 1992; 4(1):36-7. PubMed ID: 1605991
[No Abstract] [Full Text] [Related]
5. Screening for ovarian cancer. Still controversial, but encouraging.
Wald N; Parkes C
BMJ; 1993 Jun; 306(6893):1684. PubMed ID: 8324444
[No Abstract] [Full Text] [Related]
6. Screening for ovarian cancer.
Webb MJ
BMJ; 1993 Apr; 306(6884):1015-6. PubMed ID: 8369042
[No Abstract] [Full Text] [Related]
7. Screening for early ovarian cancer.
Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer screening: new trial tries new twists.
McNeil C
J Natl Cancer Inst; 1995 Sep; 87(17):1283-5. PubMed ID: 7658479
[No Abstract] [Full Text] [Related]
9. Ovarian cancer screening.
Kurjak A; Predanic M
Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
[TBL] [Abstract][Full Text] [Related]
10. CA-125 as a screening test for ovarian cancer.
Gocze PM; Freeman DA
JAMA; 1993 Jun 23-30; 269(24):3106-7. PubMed ID: 8505808
[No Abstract] [Full Text] [Related]
11. Ovarian cancer.
van Nagell JR
Gynecol Oncol; 1991 Nov; 43(2):89-91. PubMed ID: 1743563
[No Abstract] [Full Text] [Related]
12. Ovarian cancer screening. The search for cost-effective methods.
Williams L
Postgrad Med; 1992 Dec; 92(8):63-6, 72. PubMed ID: 1454673
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk and screening techniques for epithelial ovarian cancer. ACOG Committee Opinion: Committee on Gynecologic Practice. Number 117--December 1992.
Int J Gynaecol Obstet; 1993 Jun; 41(3):321-3. PubMed ID: 8102999
[No Abstract] [Full Text] [Related]
14. Screening for ovarian cancer: not worthwhile for most patients.
Wong JG; Feussner JR
N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
[No Abstract] [Full Text] [Related]
15. Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
Bast R; Woolas R
BMJ; 1993 Jun; 306(6893):1684-5. PubMed ID: 8324445
[No Abstract] [Full Text] [Related]
16. The effectiveness of ovarian cancer screening. A decision analysis model.
Schapira MM; Matchar DB; Young MJ
Ann Intern Med; 1993 Jun; 118(11):838-43. PubMed ID: 8480957
[TBL] [Abstract][Full Text] [Related]
17. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
Jacobs IJ; Oram DH; Bast RC
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
[TBL] [Abstract][Full Text] [Related]
18. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
[TBL] [Abstract][Full Text] [Related]
19. The value of CA 125 serum assay in the management of ovarian cancer. Commentary.
Jacobs I; Oram D
Br J Obstet Gynaecol; 1987 Aug; 94(8):819-21. PubMed ID: 3478081
[No Abstract] [Full Text] [Related]
20. Screening for ovarian cancer. Other chronic diseases affect serum marker.
Tambyah P; Yap I; Lye WC
BMJ; 1993 Jun; 306(6893):1684; author reply 1685-6. PubMed ID: 8369066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
